Juan Ramón
Larrubia Marfil
Profesor/a Asociado/a en CC. de la Salud
Miguel
Torralba González de Suso
Profesor/a Asociado/a en CC. de la Salud
Miguel Torralba González de Suso-rekin lankidetzan egindako argitalpenak (7)
2024
-
Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain
Annals of Pharmacotherapy, Vol. 58, Núm. 2, pp. 140-147
-
HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality
Frontiers in Immunology, Vol. 15
-
IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection
iScience, Vol. 27, Núm. 1
2022
-
Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort—authors' reply
Alimentary Pharmacology and Therapeutics
-
Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B
Alimentary Pharmacology and Therapeutics, Vol. 55, Núm. 12, pp. 1545-1559